These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 34499320)
21. Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine. Lin TH; Chen HW; Hsiao YJ; Yan JY; Chiang CY; Chen MY; Hu HM; Wu SH; Pan CH Front Immunol; 2020; 11():546. PubMed ID: 32300346 [TBL] [Abstract][Full Text] [Related]
22. Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes. Lecouturier V; Berry C; Saulnier A; Naville S; Manin C; Girerd-Chambaz Y; Crowe JE; Jackson N; Guy B Vaccine; 2019 Jul; 37(32):4601-4609. PubMed ID: 29706291 [TBL] [Abstract][Full Text] [Related]
23. Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection. Martinez DR; Metz SW; Baric RS Cell Host Microbe; 2021 Jan; 29(1):13-22. PubMed ID: 33444553 [TBL] [Abstract][Full Text] [Related]
24. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice. Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412 [TBL] [Abstract][Full Text] [Related]
25. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes. Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892 [TBL] [Abstract][Full Text] [Related]
27. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice. Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679 [TBL] [Abstract][Full Text] [Related]
28. Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine. Gromowski GD; Henein S; Kannadka CB; Barvir DA; Thomas SJ; de Silva AM; Jarman RG Vaccine; 2018 Apr; 36(18):2403-2410. PubMed ID: 29602701 [TBL] [Abstract][Full Text] [Related]
29. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence. Sun J; Li M; Wang Y; Hao P; Jin X Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441 [TBL] [Abstract][Full Text] [Related]
30. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization. Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259 [TBL] [Abstract][Full Text] [Related]
36. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279 [TBL] [Abstract][Full Text] [Related]
37. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies. Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550 [TBL] [Abstract][Full Text] [Related]
38. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses. Brandler S; Ruffie C; Najburg V; Frenkiel MP; Bedouelle H; Desprès P; Tangy F Vaccine; 2010 Sep; 28(41):6730-9. PubMed ID: 20688034 [TBL] [Abstract][Full Text] [Related]
39. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination. Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369 [TBL] [Abstract][Full Text] [Related]
40. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies. Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K mBio; 2020 Apr; 11(2):. PubMed ID: 32265332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]